PRESS RELEASE published on 05/15/2023 at 19:00, 2 years 6 months ago Abivax announces its ordinary and extraordinary general meeting of June 5, 2023, and the availability of the preparatory documents
PRESS RELEASE published on 05/04/2023 at 18:00, 2 years 7 months ago Abivax publishes Universal Registration Document 2023 “Document d’Enregistrement Universel”
PRESS RELEASE published on 05/02/2023 at 18:00, 2 years 7 months ago Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients
PRESS RELEASE published on 04/28/2023 at 19:00, 2 years 7 months ago Abivax postpones the publication of its 2023 Universal Registration Document
PRESS RELEASE published on 04/19/2023 at 21:00, 2 years 7 months ago Abivax reports 2022 financial results and operations update
PRESS RELEASE published on 04/18/2023 at 18:00, 2 years 7 months ago Abivax appoints Michael Ferguson as Chief Commerical Officer
PRESS RELEASE published on 04/17/2023 at 18:00, 2 years 7 months ago Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
PRESS RELEASE published on 04/05/2023 at 19:30, 2 years 7 months ago Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
PRESS RELEASE published on 03/16/2023 at 18:30, 2 years 8 months ago Abivax adjusts its 2023 Financial Communication Calendar
PRESS RELEASE published on 03/13/2023 at 12:00, 2 years 8 months ago Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution
Published on 12/05/2025 at 02:35, 4 hours 36 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 11 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 6 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 11 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 11 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 41 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 20 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 46 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 56 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 11 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 26 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 27 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
